FDA Approves AstraZeneca Tagrisso For Lung Cancer Treatment

November 13, 2015 4:11 PM

46 0

FDA announced the approval of AstraZenerca’s Tagrisso to treat non-small cell lung cancer

In a press release today, the US Food and Drug Administration (FDA) made an announcement that it has granted approval for an oral medication to treat patients who suffer from advanced non-small cell lung cancer (NSCLC). In this regard, AstraZeneca plc’s (NYSE:AZN) Tagrisso received FDA approval.

Also read: FDA clears 1st generic film strip of addiction drug Suboxone

Read more

To category page